147 related articles for article (PubMed ID: 16506384)
1. Efficacy of natural BALL-1 interferon-alpha treatment for patients with chronic hepatitis C and a possible enhancing effect of a twice-daily starting regimen with interferon-beta.
Ebinuma H; Saito H; Tada S; Nakamoto N; Kurita S; Kitamaura K; Horikawa H; Kumagai N; Tsuchimoto K; Ishii H; Hibi T;
Hepatogastroenterology; 2006; 53(67):94-9. PubMed ID: 16506384
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
[TBL] [Abstract][Full Text] [Related]
4. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
[TBL] [Abstract][Full Text] [Related]
5. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
[TBL] [Abstract][Full Text] [Related]
6. Twice-a-day versus once-a-day interferon-beta therapy in chronic hepatitis C.
Kaito M; Yasui-Kawamura N; Iwasa M; Kobayashi Y; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
Hepatogastroenterology; 2003; 50(51):775-8. PubMed ID: 12828083
[TBL] [Abstract][Full Text] [Related]
7. The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C.
Nakamura H; Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S
Hepatogastroenterology; 2003; 50(49):222-6. PubMed ID: 12630027
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
Fukutomi T; Fukutomi M; Iwao M; Watanabe H; Tanabe Y; Hiroshige K; Kinukawa N; Nakamuta M; Nawata H
Med Sci Monit; 2000; 6(4):692-8. PubMed ID: 11208393
[TBL] [Abstract][Full Text] [Related]
9. Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon.
Montalto G; Tripi S; Cartabellotta A; Fulco M; Soresi M; Di Gaetano G; Carroccio A; Levrero M
Am J Gastroenterol; 1998 Jun; 93(6):950-3. PubMed ID: 9647026
[TBL] [Abstract][Full Text] [Related]
10. Initial daily interferon administration can gain more eradication of HCV-RNA in patients with chronic hepatitis C, especially with serum intermediate viral load.
Nakamura H; Ito H; Ogawa H; Takeda A; Kanazawa S; Kuroda T; Yamamoto M; Enomoto H; Kimura Y; Zenda S; Terabayashi M; Saeki K; Noguchi S; Hara H; Uemiya M; Igarashi A; Hayashi E
Hepatogastroenterology; 1999; 46(26):1131-9. PubMed ID: 10370680
[TBL] [Abstract][Full Text] [Related]
11. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
Srinivas D; Mani H; Crumpler C; Van Thiel DH
Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
[TBL] [Abstract][Full Text] [Related]
12. A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors.
Yu ML; Dai CY; Chen SC; Lee LP; Huang JF; Lin ZY; Hsieh MY; Wang LY; Chuang WL; Chang WY
Antiviral Res; 2004 Jul; 63(1):25-32. PubMed ID: 15196817
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
[TBL] [Abstract][Full Text] [Related]
14. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
Muto H; Tanaka E; Matsumoto A; Yoshizawa K; Kiyosawa K;
J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139
[TBL] [Abstract][Full Text] [Related]
15. High initial dose combination regimen with interferon-alpha and ribavirin in chronic hepatitis C.
Kotzev I; Ivanova I; Atanassova M; Atanassova A; Glinkova V; Gancheva D; Shalev I; Manevska B; Krasnaliev I; Tomcheva S
Hepatogastroenterology; 2003; 50(50):463-6. PubMed ID: 12749248
[TBL] [Abstract][Full Text] [Related]
16. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
17. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
18. The importance of initial daily administration of interferon alpha for the eradication of hepatitis C virus in patients with chronic hepatitis C: a multicenter randomized trial.
Nakamura H; Ito H; Kimura Y; Takeda A; Ogawa H; Kanazawa S; Kuroda T; Inada M; Harada H; Kishimoto T; Zenda S; Terabayashi M; Saeki K; Wada M; Igarashi A; Uemiya M; Kobayashi Y; Hayashi E
Hepatogastroenterology; 1998; 45(22):1045-55. PubMed ID: 9756005
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
20. Short-term interferon therapy for chronic hepatitis C patients with low viral load.
Sato Y; Tokuue H; Kawamura N; Nezu-Yajima S; Nakajima H; Ishida H; Takahashi S
Hepatogastroenterology; 2004; 51(58):968-72. PubMed ID: 15239226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
